Clinical Trial Update: Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating HL-009 Liposomal Gel for mild to moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• HL-009 Liposomal Gel

Snippet

Sponsor: HanAll BioPharma Co., Ltd. | Conditions: Mild to Moderate Atopic Dermatitis | Phase 2 | Status: COMPLETED